Skip to main content

Day: September 20, 2021

Trident Acquisitions Corp. Files Amended Form S-4 Related to Proposed Business Combination with Lottery.com

Lottery.com also announces replay of analyst day webcast AUSTIN, Texas and NEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) — Trident Acquisitions Corp. (“Trident”) (Nasdaq: TDAC, TDACW, TDACU) announced today that it has filed an amended Form S-4 (the “Registration Statement”) with the Securities and Exchange Commission (“SEC”) in relation to its proposed business combination with AutoLotto, Inc. (“Lottery.com”), a leading technology company that is transforming how, where and when the lottery is played. This Registration Statement includes additional information related to its proposed business combination with Lottery.com, including Lottery.com’s second quarter 2021 financial statements. The Registration Statement can be accessed here. Additionally, Lottery.com hosted an analyst day webcast in connection with its proposed business...

Continue reading

Humacyte Announces Issuance of Three Additional U.S. Patents Covering its Proprietary Universally Implantable Bioengineered Human Tissue Platform

Patent estate also expanded by the issuance of 23 additional patents in international markets Humacyte now owns or licenses 119 patents covering its proprietary platformDURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the issuance of three additional U.S. patents covering its proprietary technology platform. Included in the new patents are additional claims related to the Human Acellular Vessels (HAVs), engineered, off-the-shelf replacement vessels initially being developed for vascular repair, reconstruction and replacement. New U.S. Patents 10,934,532 and 10,947,498, both titled “Tissue-engineered constructs,” expand upon existing patents encompassing...

Continue reading

Press release – Disclosure of Transactions in Own Shares – September 13 to 17, 2021

  Paris, September 20, 2021,   Disclosure of Transactions in Own Shares   In accordance with the authorization given by the shareholders’ annual meeting on July 6, 2021 to trade on its own shares and pursuant to applicable law on share repurchase, Kering (LEI: 549300VGEJKB7SVUZR78) declares the following purchases of its own shares (FR0000121485) from September 13 to 17, 2021:Issuer’s name Issuer’s identifying code Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares Market (MIC code)KERING 549300VGEJKB7SVUZR78 13/09/2021 FR0000121485 13,181 684.7668 XPARKERING 549300VGEJKB7SVUZR78 13/09/2021 FR0000121485 675 682.6511 CEUXKERING 549300VGEJKB7SVUZR78 13/09/2021 FR0000121485...

Continue reading

Arecor Announces Positive Headline Results From First Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Candidate for Diabetes

Arecor Therapeutics plc(“Arecor”, the “Company” or the “Group”) ARECOR ANNOUNCES POSITIVE HEADLINE RESULTS FROM FIRST PHASE I CLINICAL TRIAL OF AT278 ULTRA–CONCENTRATED ULTRA-RAPID ACTING INSULIN CANDIDATE FOR DIABETESAT278 delivers significantly accelerated PK/PD profile compared to NovoRapid® Potential to be first concentrated (500U/mL) ultra-rapid acting insulin product enabling miniaturisation of next generation insulin delivery devices Potential to enable more effective disease management for insulin resistant patients requiring >200 units of insulin per dayCambridge, UK, 20 September 2021. Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that its ultra-concentrated ultra-rapid acting insulin, AT278 met all of its primary and secondary...

Continue reading

India’s First Commercial Data Center completes 21 years in Operation

Sify’s facility at Vashi was the first of the 10 Company-owned Data CentersChennai, Tamil Nadu, Sept. 20, 2021 (GLOBE NEWSWIRE) — Sify Technologies Limited (NASDAQ: SIFY), India’s most comprehensive ICT solutions provider today announced that its Data Center at Vashi, the first commercial Data Center in India, completed 21 years of uninterrupted operations. Sify Technologies expanded into the Data Center business in the year 2000. Sify has built and today operates 10 carrier-neutral Data Centers, currently offering more than 70 MW IT Power. Following the facility at Vashi, Sify followed up with larger capacities in Bangalore, Chennai, Airoli, Noida, Rabale, Hyderabad and Kolkata and aims to add 200 MW in the next 4 years. Through CloudCover, Sify also services a network of 49 Data Centers across India. Delighted...

Continue reading

Allogene Therapeutics Adds Renowned CAR T Expert, Jae Park, M.D. to its Scientific Advisory Board

SOUTH SAN FRANCISCO, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today announced the appointment of Jae Park, M.D., acting Chief of Cellular Therapeutics at Memorial Sloan Kettering Cancer Center in New York, to its Scientific Advisory Board (SAB). Dr. Park, widely recognized as one of the world experts in cell therapies, is the leading principal investigator of several clinical trials in patients with non-Hodgkin lymphoma, chronic lymphocytic leukemia and acute lymphoblastic leukemia. “We are honored to welcome Dr. Park to our Scientific Advisory Board,” said Rafael Amado, M.D., Executive Vice President of Research & Development and Chief Medical Officer of Allogene....

Continue reading

Sera Prognostics to be Added to Russell 2000 Index

SALT LAKE CITY, Sept. 20, 2021 (GLOBE NEWSWIRE) — Sera Prognostics Inc., The Pregnancy Company™ (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that according to a preliminary list of initial public offering (IPO) additions to the Russell indexes, the company will be added to the Russell 2000 Index effective Sept. 20, 2021. “We are pleased to be included in the Russell 2000 Index following our transition to a public company in July,” said Gregory C. Critchfield, M.D., M.S., Chairman and CEO of Sera Prognostics. “This is the latest milestone for our company that will expand awareness of Sera within the investment community as we scale our PreTRM® test and expand revenue to build shareholder value.” About Sera Prognostics,...

Continue reading

NBC Sports Teams with SharpLink Gaming to Launch Free-to-Play, Interactive Game for the 43rd Ryder Cup Matches

Grand Prize Winner to Receive Ultimate Prize Pack MINNEAPOLIS, Sept. 20, 2021 (GLOBE NEWSWIRE) — SharpLink Gaming Ltd. (Nasdaq: SBET) (“SharpLink” or the “Company”), a pioneer of game-changing technological solutions and experience-based services for the U.S. online sports betting industry, today announced that the Company is teaming with NBC Sports to launch a new, interactive, free-to-play online game for the 43rd Ryder Cup to be held at Whistling Straits in Kohler, Wisconsin from September 24-26, 2021. Established in 1927, the Ryder Cup is a major golf competition that occurs every two years and pits 24 of the world’s best golfers comprising Team USA and Team Europe in a head-to-head match play competition. The Ryder Cup Fantasy online game will be available on www.RyderCup.com and the official Ryder Cup mobile apps for iOS...

Continue reading

Skyline Enters into $300 Million Transaction Involving the Majority Sale of Its Canadian Resort and Development Assets to Freed Corp.

Transformational transaction creates premier Canadian resort portfolio with enhanced real estate development opportunity TORONTO, Sept. 20, 2021 (GLOBE NEWSWIRE) — Skyline Investments Inc. (TASE: SKLN, “Skyline” or the “Company”) is pleased to announce that it has entered into two definitive agreements of purchase and sale (the “Transaction”) with Freed Corp. (“Freed”) for the sale of a 100% interest in its Canadian resort assets and surrounding development lands at Deerhurst Resort (“Deerhurst”) and Horseshoe Valley Resort (“Horseshoe”) as well as all of its remaining development lands at Blue Mountain Resort (“Blue Mountain”) (collectively the “Assets”) for an aggregate purchase price of $210 million. The purchase price represents approximately a $30 million premium to Skyline’s IFRS book value as at June 30, 2021. Freed, through...

Continue reading

Horizon Bank Completes Acquisition of 14 Michigan Branches, Expanding Midwest Retail Footprint

MICHIGAN CITY, Ind., Sept. 20, 2021 (GLOBE NEWSWIRE) — Horizon Bank, a wholly owned subsidiary of Horizon Bancorp, Inc. (NASDAQ GS: HBNC) (“Horizon”), announced the completion of its previously announced acquisition of 14 branches in 11 Michigan counties. The acquisition of the 14 branches and associated deposits and loans from TCF National Bank, now The Huntington National Bank, adds mass and scale to Horizon’s Midland market and extends its footprint into attractive markets in the northern and central regions of Michigan’s Lower Peninsula. “We are thrilled to welcome our newest employees and customers to Horizon Bank and look forward to serving growing numbers of consumers, small businesses, non-profits, and municipalities through our expanded Midwest footprint and this natural extension of our low-cost deposit franchise,” Chairman...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.